Skip to main content
TipRanks
Go Ultimate75% OFF

Thomas Taapken Insider Profile

4 Followers

Thomas Taapken, Chief Financial Officer at Medigene, holds ― shares in Medigene (Ticker: DE:MDG1), holds ― shares in Epigenomics (Ticker: GB:0QXH). Most recently, Thomas Taapken Sold ― shares of Medigene on Aug 28, 2018 for an estimated value of €179.61K.

Thomas Taapken's Trading History

MDG1
Medigene
Aug 28, 2018Chief Financial OfficerInformative Sell179.61K―
0QXH
Epigenomics
Jun 08, 2015ExecutiveUninformative Sell――

You May Also Like

Thomas Taapken insider profile FAQ

What is the percentage of profitable transactions made by Thomas Taapken?
The percentage of profitable transactions made by Thomas Taapken is 90%.
What is the average return per transaction made by Thomas Taapken?
The average return per transaction made by Thomas Taapken is 18.40%.
What stocks does Thomas Taapken hold?
Thomas Taapken holds: DE:MDG1, GB:0QXH stocks.
What was Thomas Taapken’s latest transaction?
Thomas Taapken’s latest transaction was an Informative Sell of €179.61K.
What was Thomas Taapken's most profitable transaction?
Thomas Taapken’s most profitable transaction was an Informative Sell of DE:MDG1 stock on August 28, 2018. The return on the trade was 58.00%.
What is Thomas Taapken's role in Medigene?
Thomas Taapken's role in Medigene is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.